Gilead increases number of participants in two trials for experimental COVID-19 treatmentMarket Watch • 04/09/20
Gilead increase number of participants in two trials for experimental COVID-19 treatmentMarket Watch • 04/09/20
Covid Report: Pfizer Selects Lead Coronavirus Drug; Gilead Updates TestsInvestors Business Daily • 04/09/20
Gilead Analyst Sees Over 50% Chance Of Success For Remdesivir In Mild-To-Moderate COVID-19Benzinga • 04/07/20
Gilead Partners Second Genome, Boosts Coronavirus Drug ProductionZacks Investment Research • 04/07/20
Gilead Analyst Sees Catalyst Ahead In Data Readout For Potential Coronavirus TreatmentBenzinga • 04/06/20
Gilead To Donate 1.5M Doses Of Experimental Coronavirus Treatment: 'The Right Thing To Do'Benzinga • 04/05/20
5 Stocks That Outperformed Last Recession And Will Likely Outperform This OneSeeking Alpha • 04/03/20